The de-prioritisation of face-to-face interactions between patients and healthcare professionals in the wake of COVID-19's current emergency has motivated a lot of changes in healthcare sys
German pharma and chemicals group Bayer may finally have put long-running litigation over its weedkiller Roundup in its rear view mirror – but at an eye-watering cost of more t
The UK’s National Institute for Health and Care Excellence (NICE) has cleared Roche’s Rozlytrek for NTRK fusion-positive solid tumours, shortly after clearing a rival drug from
Bristol-Myers Squibb $74 billion takeover of Celgene saw it shoot up the list of top 20 pharma companies by market cap into the top 10, according to a new analysis by GlobalDat